Platelet-mediated modulation of adaptive immunity

Seminars in Immunology

Volumn 28, Issue 6, 2016, Pages 555-560

  Iannacone, Matteo ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND; CHEMOKINE RECEPTOR; HERMES ANTIGEN; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 2; JUNCTIONAL ADHESION MOLECULE A; PADGEM PROTEIN; TOLL LIKE RECEPTOR; ANTITHROMBOCYTIC AGENT; CYTOKINE;

ADAPTIVE IMMUNITY; HUMAN; IMMUNOMODULATION; INFECTION; INFLAMMATION; LYMPHOCYTE; MICROORGANISM DETECTION; NONHUMAN; REVIEW; THROMBOCYTE; ANIMAL; CAPILLARY PERMEABILITY; CHEMOTAXIS; DRUG EFFECTS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; INNATE IMMUNITY; LIVER; LYMPHOCYTE ACTIVATION; METABOLISM; PATHOLOGY;

ADAPTIVE IMMUNITY; ANIMALS; BLOOD PLATELETS; CAPILLARY PERMEABILITY; CHEMOTAXIS; CYTOKINES; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; IMMUNOMODULATION; LIVER; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; PLATELET AGGREGATION INHIBITORS;

EID: 85003604992     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2016.10.008     Document Type: Review

References (25)

1. [1] Ruggeri, Z.M., Mendolicchio, G.L., Adhesion mechanisms in platelet function. Circ. Res. 100 (2007), 1673–1685, 10.1161/01.RES.0000267878.97021.ab.
2. [2] LEEKSMA, C.H., COHEN, J.A., Determination of the life of human blood platelets using labelled diisopropylfluorophosphanate. Nature 175 (1955), 552–553.
3. [3] Junt, T., Schulze, H., Chen, Z., Massberg, S., Goerge, T., Krueger, A., et al. Dynamic visualization of thrombopoiesis within bone marrow. Science 317 (2007), 1767–1770, 10.1126/science.1146304.
4. [4] Zhang, L., Orban, M., Lorenz, M., Barocke, V., Braun, D., Urtz, N., et al. A novel role of sphingosine 1-phosphate receptor S1pr1 in mouse thrombopoiesis. J. Exp. Med. 209 (2012), 2165–2181, 10.1084/jem.20121090.
5. [5] Ruggeri, Z.M., Platelet adhesion under flow. Microcirculation (New York NY: 1994) 16 (2009), 58–83, 10.1080/10739680802651477.
6. [6] Iannacone, M., Sitia, G., Isogawa, M., Whitmire, J.K., Marchese, P., Chisari, F.V., et al. Platelets prevent IFN-alpha/beta-induced lethal hemorrhage promoting CTL-dependent clearance of lymphocytic choriomeningitis virus. Proc. Natl. Acad. Sci. U. S. A. 105 (2008), 629–634, 10.1073/pnas.0711200105.
7. [7] Goerge, T., Ho-Tin-Noe, B., Carbo, C., Benarafa, C., Remold-O'Donnell, E., Zhao, B.-Q., et al. Inflammation induces hemorrhage in thrombocytopenia. Blood 111 (2008), 4958–4964, 10.1182/blood-2007-11-123620.
8. [8] Vieira-de-Abreu, A., Campbell, R.A., Weyrich, A.S., Zimmerman, G.A., Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum. Semin. Immunopathol. 34 (2012), 5–30, 10.1007/s00281-011-0286-4.
9. [9] Yeaman, M.R., Platelets: at the nexus of antimicrobial defence. Nat. Rev. Microbiol. 12 (2014), 426–437, 10.1038/nrmicro3269.
10. [10] Verschoor, A., Neuenhahn, M., Navarini, A.A., Graef, P., Plaumann, A., Seidlmeier, A., et al. A platelet-mediated system for shuttling blood-borne bacteria to CD8α+ dendritic cells depends on glycoprotein GPIb and complement C3. Nat. Immunol. 12 (2011), 1194–1201, 10.1038/ni.2140.
11. [11] Diacovo, T.G., Puri, K.D., Warnock, R.A., Springer, T.A., von Andrian, U.H., Platelet-mediated lymphocyte delivery to high endothelial venules. Science 273 (1996), 252–255.
12. [12] Herzog, B.H., Fu, J., Wilson, S.J., Hess, P.R., Sen, A., McDaniel, J.M., et al. Podoplanin maintains high endothelial venule integrity by interacting with platelet CLEC-2. Nature 502 (2013), 105–109, 10.1038/nature12501.
13. [13] Elzey, B.D., Tian, J., Jensen, R.J., Swanson, A.K., Lees, J.R., Lentz, S.R., et al. Platelet-mediated modulation of adaptive immunity. A communication link between innate and adaptive immune compartments. Immunity 19 (2003), 9–19.
14. [14] Iannacone, M., Sitia, G., Isogawa, M., Marchese, P., Castro, M.G., Lowenstein, P.R., et al. Platelets mediate cytotoxic T lymphocyte-induced liver damage. Nat. Med. 11 (2005), 1167–1169, 10.1038/nm1317.
15. [15] Iannacone, M., Sitia, G., Narvaiza, I., Ruggeri, Z.M., Guidotti, L.G., Antiplatelet drug therapy moderates immune-mediated liver disease and inhibits viral clearance in mice infected with a replication-deficient adenovirus. Clin. Vaccine Immunol. 14 (2007), 1532–1535, 10.1128/CVI.00298-07.
16. [16] Guidotti, L.G., Inverso, D., Sironi, L., Di Lucia, P., Fioravanti, J., Ganzer, L., et al. Immunosurveillance of the liver by intravascular effector CD8(+) T cells. Cell 161 (2015), 486–500, 10.1016/j.cell.2015.03.005.
17. [17] Wong, C.H.Y., Jenne, C.N., Petri, B., Chrobok, N.L., Kubes, P., Nucleation of platelets with blood-borne pathogens on Kupffer cells precedes other innate immunity and contributes to bacterial clearance. Nat. Immunol. 14 (2013), 785–792, 10.1038/ni.2631.
18. [18] Sitia, G., Iannacone, M., Aiolfi, R., Isogawa, M., van Rooijen, N., Scozzesi, C., et al. Kupffer cells hasten resolution of liver immunopathology in mouse models of viral hepatitis. PLoS Pathog., 7, 2011, e1002061, 10.1371/journal.ppat.1002061.
19. [19] Savage, B., Saldívar, E., Ruggeri, Z.M., Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 84 (1996), 289–297, 10.1016/S0092-8674(00)80983-6.
20. [20] Mazzucato, M., Pradella, P., Cozzi, M.R., De Marco, L., Ruggeri, Z.M., Sequential cytoplasmic calcium signals in a 2-stage platelet activation process induced by the glycoprotein Ibalpha mechanoreceptor. Blood 100 (2002), 2793–2800, 10.1182/blood-2002-02-0514.
21. [21] Sitia, G., Aiolfi, R., Di Lucia, P., Mainetti, M., Fiocchi, A., Mingozzi, F., et al. Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B. Proc. Natl. Acad. Sci. U. S. A. 109 (2012), E2165–72, 10.1073/pnas.1209182109.
22. [22] Nakamoto, Y., Guidotti, L.G., Kuhlen, C.V., Fowler, P., Chisari, F.V., Immune pathogenesis of hepatocellular carcinoma. J. Exp. Med. 188 (1998), 341–350.
23. [23] Nakamoto, Y., Suda, T., Momoi, T., Kaneko, S., Different procarcinogenic potentials of lymphocyte subsets in a transgenic mouse model of chronic hepatitis B. Cancer Res. 64 (2004), 3326–3333.
24. [24] Tripodi, A., Mannucci, P.M., The coagulopathy of chronic liver disease. N. Engl. J. Med. 365 (2011), 147–156, 10.1056/NEJMra1011170.
25. [25] Sahasrabuddhe, V.V., Gunja, M.Z., Graubard, B.I., Trabert, B., Schwartz, L.M., Park, Y., et al. Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma. J. Natl. Cancer Inst. 104 (2012), 1808–1814, 10.1093/jnci/djs452.